Hanmi Pharm (Korea) Today
| 128940 Stock | 319,500 3,000 0.95% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Hanmi Pharm is trading at 319500.00 as of the 3rd of May 2024, a 0.95 percent increase since the beginning of the trading day. The stock's open price was 316500.0. Hanmi Pharm has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Hanmi Pharm Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of April 2024 and ending today, the 3rd of May 2024. Click here to learn more.
Moving together with Hanmi Stock
| 0.68 | 373220 | LG Energy Solution | PairCorr |
Moving against Hanmi Stock
| 0.44 | 005930 | Samsung Electronics | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Hanmi Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hanmi Pharm's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hanmi Pharm or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Hanmi Pharm Co (128940) is traded on Korea Stock Exchange in Korea and employs 2,121 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 3.41 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hanmi Pharm's market, we take the total number of its shares issued and multiply it by Hanmi Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hanmi Pharm operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 12.48 M outstanding shares.
Hanmi Pharm generates positive cash flow from operations, but has no cash available
Check Hanmi Pharm Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Hanmi Pharm is USD3.41 Trillion. Hanmi Pharm secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Hanmi Ownership Details
Hanmi Pharm Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Hanmi Pharm market risk premium is the additional return an investor will receive from holding Hanmi Pharm long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hanmi Pharm. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Hanmi Pharm's alpha and beta are two of the key measurements used to evaluate Hanmi Pharm's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.58 | |||
| Semi Deviation | 1.79 | |||
| Standard Deviation | 2.1 | |||
| Variance | 4.43 |
Hanmi Stock Against Markets
Picking the right benchmark for Hanmi Pharm stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Hanmi Pharm stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Hanmi Pharm is critical whether you are bullish or bearish towards Hanmi Pharm Co at a given time. Please also check how Hanmi Pharm's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hanmi Pharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Hanmi Pharm Corporate Management
Elected by the shareholders, the Hanmi Pharm's board of directors comprises two types of representatives: Hanmi Pharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hanmi. The board's role is to monitor Hanmi Pharm's management team and ensure that shareholders' interests are well served. Hanmi Pharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hanmi Pharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| GwanSun Lee | Exec Strategy | Profile | |
| JongSoo Woo | Pres CEO | Profile | |
| MaengSub Kim | Head Director | Profile | |
| MoonKyee Ju | Managing Director | Profile | |
| JongWoo Park | Managing Director | Profile | |
| JongHo Lim | CSR Director | Profile | |
| JuHyun Lim | Managing Director | Profile |
How to buy Hanmi Stock?
Before investing in Hanmi Pharm, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Hanmi Pharm. To buy Hanmi Pharm stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Hanmi Pharm. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Hanmi Pharm stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Hanmi Pharm Co stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Hanmi Pharm Co stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Hanmi Pharm Co, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Hanmi Pharm Co?
The danger of trading Hanmi Pharm Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Hanmi Pharm is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Hanmi Pharm. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Hanmi Pharm is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Hanmi Pharm Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Hanmi Pharm information on this page should be used as a complementary analysis to other Hanmi Pharm's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Hanmi Stock analysis
When running Hanmi Pharm's price analysis, check to measure Hanmi Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hanmi Pharm is operating at the current time. Most of Hanmi Pharm's value examination focuses on studying past and present price action to predict the probability of Hanmi Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hanmi Pharm's price. Additionally, you may evaluate how the addition of Hanmi Pharm to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |